Literature DB >> 11525770

Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory.

T M DeLorey1, R C Lin, B McBrady, X He, J M Cook, J Lameh, G H Loew.   

Abstract

Eight compounds that bind to the benzodiazepine binding site on the gamma-amino butyric acid(A) (GABA(A)) receptor were assessed for their influence on contextual memory, an aspect of memory affected in various cognitive disorders including Alzheimer's disease. Using a Pavlovian fear-conditioning paradigm, each ligand was evaluated in C57Bl/6 mice in regards to its direct affect on contextual memory and whether the ligand could attenuate scopolamine-induced contextual memory impairment. Of the eight ligands tested, one impaired contextual memory (agonist), six attenuated scopolamine-induced contextual memory impairment (inverse agonists), and one antagonized the ability of an inverse agonist to attenuate scopolamine-induced contextual memory impairment. Hence, further demonstrating the bi-directional influence benzodiazepine binding site ligands are able to exert on memory modulation. This study serves as an initial starting point in the development of pharmacological tools to be used in deciphering how GABA(A) receptors influence contextual memory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525770     DOI: 10.1016/s0014-2999(01)01199-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].

Authors:  Paul L Soto; Nancy A Ator; Sundari K Rallapalli; Poonam Biawat; Terry Clayton; James M Cook; Michael R Weed
Journal:  Neuropsychopharmacology       Date:  2013-05-31       Impact factor: 7.853

2.  The context preexposure facilitation effect in mice: a dose-response analysis of pretraining scopolamine administration.

Authors:  Kevin L Brown; John A Kennard; Daniel J Sherer; David M Comalli; Diana S Woodruff-Pak
Journal:  Behav Brain Res       Date:  2011-07-30       Impact factor: 3.332

3.  Superadditive effects of ethanol and flunitrazepam: implications of using immunopharmacotherapy as a therapeutic.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Mol Pharm       Date:  2010-09-17       Impact factor: 4.939

4.  Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

Authors:  Xia Li; Victoria B Risbrough; Chelsea Cates-Gatto; Katarzyna Kaczanowska; M G Finn; Amanda J Roberts; Athina Markou
Journal:  Neuropharmacology       Date:  2013-01-29       Impact factor: 5.250

5.  Prevention of drug-induced memory impairment by immunopharmacotherapy.

Authors:  Jennifer B Treweek; Chengzao Sun; Alexander V Mayorov; Longwu Qi; Coree L Levy; Amanda J Roberts; Tobin J Dickerson; Kim D Janda
Journal:  J Med Chem       Date:  2008-10-16       Impact factor: 7.446

Review 6.  A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.

Authors:  Terry Clayton; Michael M Poe; Sundari Rallapalli; Poonam Biawat; Miroslav M Savić; James K Rowlett; George Gallos; Charles W Emala; Catherine C Kaczorowski; Douglas C Stafford; Leggy A Arnold; James M Cook
Journal:  Int J Med Chem       Date:  2015-11-10

7.  Relationships between GAT1 and PTSD, Depression, and Substance Use Disorder.

Authors:  Kaitlin E Bountress; Wei Wei; Christina Sheerin; Dongjun Chung; Ananda B Amstadter; Howard Mandel; Zhewu Wang
Journal:  Brain Sci       Date:  2017-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.